Advertisement
Research ArticleDrug Discovery and Translational Medicine

The Novel Kinase Inhibitor PRT062070 (Cerdulatinib) Demonstrates Efficacy in Models of Autoimmunity and B-Cell Cancer

Greg Coffey, Andreas Betz, Francis DeGuzman, Yvonne Pak, Mayuko Inagaki, Dale C. Baker, Stanley J. Hollenbach, Anjali Pandey and Uma Sinha
Journal of Pharmacology and Experimental Therapeutics December 2014, 351 (3) 538-548; DOI: https://doi.org/10.1124/jpet.114.218164
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleDrug Discovery and Translational Medicine

Efficacy of PRT062070 in Models of Autoimmunity and Cancer

Greg Coffey, Andreas Betz, Francis DeGuzman, Yvonne Pak, Mayuko Inagaki, Dale C. Baker, Stanley J. Hollenbach, Anjali Pandey and Uma Sinha
Journal of Pharmacology and Experimental Therapeutics December 1, 2014, 351 (3) 538-548; DOI: https://doi.org/10.1124/jpet.114.218164
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement